tiprankstipranks
Advertisement
Advertisement
Boston Scientific’s POLARx Study Completion Adds Fresh Data to Atrial Fibrillation Growth Story
PremiumCompany AnnouncementsBoston Scientific’s POLARx Study Completion Adds Fresh Data to Atrial Fibrillation Growth Story
15d ago
Boston Scientific Advances Liver Cancer Strategy With New TheraSphere Dosimetry Study
Premium
Company Announcements
Boston Scientific Advances Liver Cancer Strategy With New TheraSphere Dosimetry Study
20d ago
Boston Scientific price target lowered to $65 from $75 at Stifel
Premium
The Fly
Boston Scientific price target lowered to $65 from $75 at Stifel
20d ago
Boston Scientific price target lowered to $65 from $90 at Piper Sandler
PremiumThe FlyBoston Scientific price target lowered to $65 from $90 at Piper Sandler
1M ago
Boston Scientific price target lowered to $61 from $68 at BofA
Premium
The Fly
Boston Scientific price target lowered to $61 from $68 at BofA
1M ago
Boston Scientific Targets Diabetes and Obesity With New ESG Trial
Premium
Company Announcements
Boston Scientific Targets Diabetes and Obesity With New ESG Trial
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100